World's Best Scientists 2026 revealed!
Jay M. Short

Jay M. Short

D-Index & Metrics

Molecular Biology

D-Index
55
Citations
17579
World Ranking
2244
National Ranking
1107

Jay M. Short publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Jay M. Short sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 82 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Jay M. Short D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Jay M. Short sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 55 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Jay M. Short is affiliated with LusBio in the United States and has a research focus that spans several fields within biomedical sciences. Their work primarily intersects Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology.

The scientist's research covers a variety of specialized subfields including Radiology, Nuclear Medicine and Imaging, Oncology, Immunology, Molecular Biology, and Biotechnology. The main topics of their work include Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Glycosylation and Glycoproteins Research, Cancer Research and Treatments, Nanoplatforms for cancer theranostics, Advanced Biosensing Techniques and Applications, and Galectins and Cancer Biology.

Jay M. Short has numerous publications concentrated in several key scientific venues. Frequent publication outlets for their work include:

  • Cancer Research
  • mAbs
  • Regular and Young Investigator Award Abstracts
  • Proceedings of the National Academy of Sciences
  • Antibody Therapeutics

Among recent notable papers, there are:

  • Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches, 2021, Proceedings of the National Academy of Sciences
  • A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy, 2024, mAbs
  • Preclinical development of ozuriftamab vedotin (BA3021), a novel ROR2-specific conditionally active biologic antibody-drug conjugate, 2025, mAbs
  • Preclinical development of mecbotamab vedotin (BA3011), a novel, AXL-specific conditional active biologic antibody-drug conjugate, 2025, Antibody Therapeutics
  • Abstract 4560: Conditionally active biologics (CAB): A novel class of molecules targeting solid tumors, 2020, Cancer Research

Frequent co-authors collaborating with Jay M. Short include:

  • Gerhard Frey
  • Haizhen Liu
  • William J. Boyle
  • Cathy Chang
  • Charles Xing

Best Publications

  • Comparative Metagenomics of Microbial Communities

    Susannah Green Tringe;Christian von Mering;Arthur Kobayashi;Asaf A. Salamov

  • λ ZAP: a bacteriophage λ expression vector with in vivo excision properties

    Jay M. Short;Joseph M. Fernandez;Joseph A. Sorge;William D. Huse

  • The complete genome of the hyperthermophilic bacterium Aquifex aeolicus

    Gerard Deckert;Patrick V. Warren;Terry Gaasterland;William G. Young

  • Genome Streamlining in a Cosmopolitan Oceanic Bacterium

    Stephen J. Giovannoni;H. James Tripp;Scott Givan;Mircea Podar

  • Cultivating the uncultured

    Karsten Zengler;Gerardo Toledo;Michael Rappé;James Elkins

  • High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus

    Kelly S. Lundberg;Dan D. Shoemaker;Michael W.W. Adams;Jay M. Short

  • The genome of Nanoarchaeum equitans: Insights into early archaeal evolution and derived parasitism

    Elizabeth Waters;Michael J. Hohn;Ivan Ahel;David E. Graham

  • Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.

    S W Kohler;G S Provost;A Fieck;P L Kretz

  • Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. II. Identification of cAMP and glucocorticoid regulatory domains.

    J. M. Short;Anthony Wynshaw-Boris;H. P. Short;R. W. Hanson

  • pBluescript II: gene mapping vectors

    M.A. Alting-Mees;J.M. Short

  • Method of DNA reassembly by interrupting synthesis

    Jay M. Short

  • Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: construction of a heavy chain variable region-specific cDNA library.

    L Sastry;M Alting-Mees;W D Huse;J M Short

  • A Novel, High Performance Enzyme for Starch Liquefaction: DISCOVERY AND OPTIMIZATION OF A LOW pH, THERMOSTABLE α-AMYLASE *

    Toby H. Richardson;Xuqiu Tan;Gerhard Frey;Walter Callen

  • Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/lacl shuttle vector

    S W Kohler;G S Provost;A Fieck;P L Kretz

  • The use of shuttle vectors for mutation analysis in transgenic mice and rats

    Dycaico Mj;Provost Gs;Kretz Pl;Ransom Sl

  • Exploring nitrilase sequence space for enantioselective catalysis.

    Dan E. Robertson;Jennifer A. Chaplin;Grace DeSantis;Mircea Podar

  • Production of enzymes having desired activities by mutagenesis

    Jay M. Short

  • High throughput screening for novel enzymes

    Jay M. Short;Martin Keller

  • Transgenic systems for in vivo mutation analysis.

    Provost Gs;Kretz Pl;Hamner Rt;Matthews Cd

  • Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library.

    R L Mullinax;E A Gross;J R Amberg;B N Hay

Frequent Co-Authors

Anthony Wynshaw-Boris
Anthony Wynshaw-Boris Case Western Reserve University
Mircea Podar
Mircea Podar Oak Ridge National Laboratory
Richard W. Hanson
Richard W. Hanson Case Western Reserve University
Geoffrey P. Hazlewood
Geoffrey P. Hazlewood Babraham Institute
Edward M. Rubin
Edward M. Rubin Joint Genome Institute
Paul Dupree
Paul Dupree University of Cambridge
Steve S. Sommer
Steve S. Sommer Medomics (United States)
Christian von Mering
Christian von Mering University of Zurich
James C. Carrington
James C. Carrington Donald Danforth Plant Science Center
Stephen J. Giovannoni
Stephen J. Giovannoni Oregon State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Molecular Biology in the USA provides a strong foundation for various career paths, both within life sciences and beyond. Graduates often pursue roles in research, healthcare, biotechnology, and education. For those interested in broadening their skillset or changing careers, exploring related online degrees can be an excellent option.

If you're considering supporting individuals with communication disorders in schools, you might be interested in learning what is an slp in education. Alternatively, if you’re fascinated by design or structure, exploring an architect degree online can open new doors in the architectural field.

Analytical skills gained in molecular biology also align well with mathematics. Enrolling in an online math degree program adds value for careers involving data science or bioinformatics. For those drawn to creative and visual aspects, online graphic design schools offer flexible paths towards careers in digital media, making your molecular biology expertise even more versatile.

Best Scientists Citing Jay M. Short

Trending Scientists

Recently Published Articles